#childhood cancer

A CAR T-Cell Therapy for Multiple Childhood Cancers?

Every year, 350 children in the United States are diagnosed with rhabdomyosarcoma.

Combination therapy using Taflinar and Mekinst led to improved response for pediatric patients with low-grade gliomas

Latino children and those with public insurance had poorer survival even if they received the same treatment in clinical trials.

The collaboration will address disparities in cancer care in high-income and lower-income countries.

Thirty-five years post-cancer diagnosis, one in seven survivors developed new cancer and one in 16 survivors died from new cancer.

Minimal residual disease status may not be as strong a predictor of relapse in Latino children.

Pediatric patients were matched to therapies targeting specific mutations found in their cancers.

Research led by Adam Green, MD, shows the five-year survival rates for children ages 0 to 3 months is half that of children ages 1 to 19.

Women with a history of childhood cancer have a “really good chance of getting pregnant” and staying healthy. But know the risks.

A sterilization plant in Texas emits large amounts of ethylene oxide, which increases the risk of leukemia, especially in children.

Studies point to strategies to reduce disparities, improve outcomes and support shared decision-making.

A single mom driving all night with her sick child because she can’t afford a hotel room? That’s what cancer means in the United States.

Although most young people survive cancer, secondary effects from the illness and its treatment can increase future health risks.

All the children with acute promyelocytic leukemia (APL) were able to avoid chemotherapy or have a very short course.

For Childhood Cancer Awareness Month, the National Cancer Institute’s Director Dr. Ned Sharpless reflects on childhood cancer progress.

Adolescents and young adults are using mobile devices to document the impact of cancer and its treatment on their quality of life.